metastasectomy is the surgical removal of one or more secondary malignant tumors that have disseminated from a primary cancer site to a distant organ or tissue. It is distinguished from a primary tumorresection (lumpectomy, lobectomy, nephrectomy), which targets the original source of the cancer, and from cytoreduction (debulking), which aims to reduce tumor volume rather than achieve complete microscopic clearance. The underlying pathological mechanism involves the hematogenous or lymphatic spread of malignant cells that survive circulation and establish viable colonies in distant capillary beds (e.g., lungs, liver, brain, bone). While historically considered a palliative measure, metastasectomy is increasingly performed with curative intent in patients with oligometastatic disease (typically defined as 1-5 metastatic lesions), particularly in cancers like renal cell carcinoma (RCC), colorectal cancer, and melanoma. The clinically relevant forms most commonly encountered in coding include pulmonary metastasectomy (C78.0-), hepatic metastasectomy (C78.7), and resection of brain metastases (C79.31). It is commonly confused with lymphadenectomy; however, a lymphadenectomy removes regional lymphatic drainage basins that may contain cancer, whereas a metastasectomy typically refers to the removal of distant, solid organ metastases.
Noun-forming suffix — “surgical excision or removal”
The word entered English in the 1930s as metastasectomy (noun), formed by combining the established medical term metastasis (borrowed from Late Latin, from Greek metastasis) with the surgical suffix -ectomy — literally “excision of that which has changed its place.” The root stasis (“standing/position”) connects metastasectomy to the entire -STASIS FAMILY: hemostasis (blood + standing → stopping of bleeding), homeostasis (same + standing → stable internal environment), and fungistasis (inhibition of fungal growth). The prefix meta- is highly productive in medical terminology, appearing in metabolism, metaplasia, and metacarpal.
🔀 ALIASES / ALTERNATE TERMS
Metastatic resection(clinical synonym — commonly used in operative reports, e.g., “hepatic metastatic resection”)
Secondary tumor excision(lay and clinical synonym — often used in patient-facing materials and general oncology settings)
Oligometastasis resection(clinical descriptor synonym — specific to the removal of a limited number of metastatic tumors, usually 1-5, with curative intent)
Pulmonary metastasectomy(organ-specific subtype — removal of lung metastases, frequently performed via VATS; coded under C78.0x)
Hepatic metastasectomy(organ-specific subtype — removal of liver metastases, common in colorectal cancer spread; C78.7)
Adrenal metastasectomy(organ-specific subtype — removal of adrenal metastases, highly relevant in urologic oncology for advanced RCC; C79.82)
Cerebral metastasectomy(organ-specific subtype — neurosurgical removal of brain metastases; C79.31)
🔗 RELATED TERMS
Primary tumor resection — the opposite/counterpart of metastasectomy; the surgical removal of the original cancer site (e.g., radical prostatectomy for prostate cancer) rather than its distant spread.
Metastasis — shares the stas- root; the secondary malignant tumor itself, which is the target of the metastasectomy procedure.
Oligometastatic disease — an intermediate state of cancer spread characterized by a limited number of metastases (usually <5) in a limited number of organs, making metastasectomy a viable curative strategy.
Cytoreduction — surgical removal of part of a malignant tumor which cannot be completely excised (debulking); unlike metastasectomy, it does not typically achieve R0 (microscopically negative) margins.
Hematogenous spread — the physiological mechanism of cancer cells traveling through the bloodstream to distant organs, creating the lesions targeted by metastasectomy.
Lymphadenectomy — surgical removal of one or more groups of lymph nodes; distinct from metastasectomy, though both remove cancer that has spread from the primary site.
Renal Cell Carcinoma — a urologic malignancy (C64.x) known for late, isolated metastases (e.g., to the pancreas, lungs, or contralateral adrenal gland) that are frequently treated with metastasectomy.
Squamous Cell Carcinoma of Head and Neck — an ENT malignancy where distant metastases (e.g., pulmonary) may occasionally be resected if the primary neck disease is controlled.
CODING CORNER
🏥 ICD-10-CM CODES
Secondary Malignant Neoplasm of Respiratory and Digestive Organs (C78.x)
Radical resection of tumor, bone; tibia (Example of orthopedic/bone metastasectomy)
⚠️ Coding Note: For inpatient and profee coding, sequencing is critical when a patient is admitted specifically for a metastasectomy. According to ICD-10-CM Official Guidelines, if the treatment is directed solely toward the secondary site (the metastasis), the secondary neoplasm code (e.g., C78.01 for right lung metastasis) must be sequenced as the principal/first-listed diagnosis. The primary malignancy is coded as an additional diagnosis if it is still present and actively being treated (e.g., C64.1 for right renal cell carcinoma). If the primary cancer was previously excised or eradicated and is no longer receiving active treatment, assign a personal history code (e.g., Z85.528 for history of kidney cancer) instead of the active primary code. Undercoding alert: When coding pulmonary metastasectomies via VATS, watch for the documentation trigger “multiple wedge resections” or “additional nodules excised.” Coders frequently miss the add-on code 32667 for each additional ipsilateral wedge resection. Ensure the operative report clearly states therapeutic excision with margins (R0 intent) rather than a simple biopsy, as biopsies map to different CPTs and lower-weighted MS-DRGs.